406 related articles for article (PubMed ID: 15712608)
21. Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Méndez CC; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
Med Mycol; 2008 Mar; 46(2):119-23. PubMed ID: 18324490
[TBL] [Abstract][Full Text] [Related]
22. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
24. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.
Fernández-Torres B; Cabañes FJ; Carrillo-Muñoz AJ; Esteban A; Inza I; Abarca L; Guarro J
J Clin Microbiol; 2002 Nov; 40(11):3999-4003. PubMed ID: 12409365
[TBL] [Abstract][Full Text] [Related]
25. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.
Jessup CJ; Warner J; Isham N; Hasan I; Ghannoum MA
J Clin Microbiol; 2000 Jan; 38(1):341-4. PubMed ID: 10618112
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of a soil isolate of Pseudomonas chlororaphis against medically important dermatophytes and identification of a phenazine-like compound as its bioactive metabolite.
Ranjbariyan A; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2014 Jun; 24(2):e57-64. PubMed ID: 24746720
[TBL] [Abstract][Full Text] [Related]
28. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
29. Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods.
Mota CR; Miranda KC; Lemos Jde A; Costa CR; Hasimoto e Souza LK; Passos XS; Meneses e Silva H; Silva Mdo R
Rev Soc Bras Med Trop; 2009; 42(3):250-4. PubMed ID: 19684970
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique.
Butty P; Lebecq JC; Mallié M; Bastide JM
J Med Vet Mycol; 1995; 33(6):403-9. PubMed ID: 8683409
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
Karaca N; Koç AN
Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers.
Kermani F; Javidnia J; Hedayati MT; Abastabar M; Haghani I; Didehdar M; Fami Zaghrami M; Shokohi T
Mycoses; 2020 Dec; 63(12):1321-1330. PubMed ID: 32854165
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the in vitro activity of terbinafine.
Jessup CJ; Ryder NS; Ghannoum MA
Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
36. Antidermatophytic activity of allylamine derivatives.
Venugopal PV; Venugopal TV
Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
[TBL] [Abstract][Full Text] [Related]
37. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of lichen compounds against dermatophytes: a review.
Furmanek Ł; Czarnota P; Seaward MRD
J Appl Microbiol; 2019 Aug; 127(2):308-325. PubMed ID: 30664814
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
[TBL] [Abstract][Full Text] [Related]
40. A study of dermatophytes and their in-vitro antifungal sensitivity.
Sumana MN; Rajagopal V
Indian J Pathol Microbiol; 2002 Apr; 45(2):169-72. PubMed ID: 12696733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
